Estatinas y riesgo de diabetes / Use of statins and the risk of new onset diabetes mellitus
Rev. chil. cardiol
; 31(3): 232-237, 2012.
Article
in Spanish
| LILACS
| ID: lil-670194
Responsible library:
CL325.1
RESUMEN
Se ha descrito relación entre el uso de estatinas y aparición de nueva diabetes. Se revisa advertencia de la FDA, así como análisis de estudios y meta análisis, que permiten deducir una acción de las estatinas que favorece el desarrollo de nueva diabetes. Las precauciones del uso de estatinas se deben orientar a pacientes con factores de riesgo de diabetes en prevención primaria cardiovascular. Se expresa la necesidad de estudios prospectivos con objetivos primarios específicos, para mayor precisión de información y adopción de recomendaciones basadas en alto nivel de evidencias.
ABSTRACT
Relationship between statin use and appearance of new diabetes has been described. We review the FDA warning and analysis of studies and meta-analysis, which point to an action of statins which favors the development of new diabetes. Precautions of statin use should guide patients with risk factors for diabetes in primary cardiovascular prevention. It expresses the need for prospective studies with specific primary objectives, for accuracy of information and making recommendations based on high-level evidence.
Full text:
Available
Collection:
International databases
Health context:
SDG3 - Health and Well-Being
Health problem:
Target 3.4: Reduce premature mortality due to noncommunicable diseases
Database:
LILACS
Main subject:
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/
Diabetes Mellitus
Type of study:
Etiology study
/
Observational study
/
Risk factors
/
Systematic review
Limits:
Humans
Language:
Spanish
Journal:
Rev. chil. cardiol
Journal subject:
Cardiology
Year:
2012
Document type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Universidad Andrés Bello/CL